相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。International consensus recommendations on the management of people with haemophilia B
Daniel P. Hart et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2022)
Population pharmacokinetic (PopPK) modelling indicates that patients switching to BAY 81-8973 from rFVIII-FS can continue their dosing schedule with improved protection
Alexander Solms et al.
HAEMOPHILIA (2020)
Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data
Joao A. Abrantes et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate®) and BAY 81-8973 (KovaltryA®) in patients with severe or moderate haemophilia A in prophylaxis
Juan Eduardo Megias-Vericat et al.
HAEMOPHILIA (2019)
Haemophilia B: Where are we now and what does the future hold?
Gerry Dolan et al.
BLOOD REVIEWS (2018)
Effects of the FcRn developmental pharmacology on the pharmacokinetics of therapeutic monoclonal IgG antibody in pediatric subjects using minimal physiologically-based pharmacokinetic modelling
Deni Hardiansyah et al.
MABS (2018)
Extended Half-Life Factor VIII and Factor IX Preparations
Lukas Graf
TRANSFUSION MEDICINE AND HEMOTHERAPY (2018)
Population pharmacokinetics of factor IX in hemophilia B patients undergoing surgery
T. Preijers et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations
Alfonso Iorio et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Pharmacokinetics of plasma-derived and recombinant factor IX - implications for prophylaxis and on-demand therapy
S. Bjorkman
HAEMOPHILIA (2013)
An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B
P. M. Rallapalli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B
Jerry S. Powell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development-Part 2: Introduction to Pharmacokinetic Modeling Methods
Dr Mould et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
DA Roth et al.
BLOOD (2001)
分享论文
